$1.68 Billion is the total value of Cormorant Asset Management, LP's 78 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 29.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ERASCA INC | $163,676,000 | -24.5% | 10,505,550 | 0.0% | 9.74% | +10.5% | ||
| TPTX | Buy | TURNING POINT THERAPEUTICS I | $144,292,000 | -23.6% | 3,025,000 | +6.4% | 8.58% | +11.9% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $116,480,000 | +47.8% | 5,440,453 | +1.4% | 6.93% | +116.4% |
| RXDX | PROMETHEUS BIOSCIENCES INC | $73,071,000 | +66.8% | 1,848,024 | 0.0% | 4.35% | +144.2% | |
| FMTX | Sell | FORMA THERAPEUTICS HLDGS INC | $65,981,000 | -39.7% | 4,639,995 | -1.7% | 3.92% | -11.8% |
| GLUE | Sell | MONTE ROSA THERAPEUTICS INC | $61,305,000 | -9.8% | 3,002,199 | -3.2% | 3.65% | +32.1% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $61,210,000 | -29.2% | 2,431,852 | -22.7% | 3.64% | +3.6% |
| EWTX | Buy | EDGEWISE THERAPEUTICS INC | $54,487,000 | -2.6% | 3,565,901 | +5.8% | 3.24% | +42.5% |
| Buy | TANGO THERAPEUTICS INC | $53,149,000 | +8.9% | 4,899,185 | +25.6% | 3.16% | +59.4% | |
| RNA | Sell | AVIDITY BIOSCIENCES INC | $47,828,000 | -10.2% | 2,012,115 | -6.9% | 2.84% | +31.5% |
| VERV | Buy | VERVE THERAPEUTICS INC | $40,897,000 | +25.2% | 1,109,224 | +56.4% | 2.43% | +83.3% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $39,845,000 | +357.9% | 500,000 | +400.0% | 2.37% | +569.5% |
| Buy | IMMUNEERING CORP | $37,233,000 | -36.3% | 2,302,626 | +2.2% | 2.22% | -6.7% | |
| BCAB | Sell | BIOATLA INC | $33,000,000 | -38.3% | 1,681,115 | -7.4% | 1.96% | -9.6% |
| CYTK | Sell | CYTOKINETICS INC | $31,906,000 | -10.7% | 700,000 | -30.0% | 1.90% | +30.7% |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $31,575,000 | +1.4% | 1,403,331 | -2.9% | 1.88% | +48.5% |
| RAIN | RAIN THERAPEUTICS INC | $29,967,000 | -13.9% | 2,326,660 | 0.0% | 1.78% | +26.0% | |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $29,550,000 | -3.1% | 625,000 | -32.4% | 1.76% | +41.9% |
| STOK | Sell | STOKE THERAPEUTICS INC | $28,365,000 | -12.8% | 1,182,362 | -7.5% | 1.69% | +27.7% |
| CNTA | Buy | CENTESSA PHARMACEUTICALS PLCsponsored ads | $28,036,000 | -2.4% | 2,489,894 | +44.2% | 1.67% | +42.9% |
| BBIO | Sell | BRIDGEBIO PHARMA INC | $27,837,000 | -66.4% | 1,668,909 | -5.7% | 1.66% | -50.8% |
| BMEA | BIOMEA FUSION INC | $23,623,000 | -37.8% | 3,170,872 | 0.0% | 1.40% | -8.9% | |
| AMAM | AMBRX BIOPHARMA INCsponsored ads | $22,452,000 | -32.2% | 2,486,386 | 0.0% | 1.34% | -0.7% | |
| AVTE | Sell | AEROVATE THERAPEUTICS INC | $21,584,000 | -48.6% | 1,830,691 | -9.8% | 1.28% | -24.7% |
| OLMA | Sell | OLEMA PHARMACEUTICALS INC | $20,310,000 | -76.0% | 2,169,871 | -29.4% | 1.21% | -64.9% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $18,960,000 | -34.5% | 868,550 | -10.3% | 1.13% | -4.1% |
| TALS | Sell | TALARIS THERAPEUTICS INC | $18,081,000 | +10.6% | 1,182,545 | -2.7% | 1.08% | +61.9% |
| AXNX | AXONICS INC | $18,045,000 | -14.0% | 322,240 | 0.0% | 1.07% | +25.9% | |
| ALXO | Sell | ALX ONCOLOGY HLDGS INC | $16,377,000 | -78.1% | 762,079 | -24.7% | 0.97% | -67.9% |
| New | VENTYX BIOSCIENCES INC | $15,128,000 | – | 785,303 | +100.0% | 0.90% | – | |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $15,014,000 | -91.3% | 1,679,442 | -65.9% | 0.89% | -87.3% |
| PRAX | Sell | PRAXIS PRECISION MEDICINES I | $14,822,000 | -21.7% | 752,406 | -26.5% | 0.88% | +14.7% |
| IGMS | Buy | IGM BIOSCIENCES INC | $14,665,000 | -36.3% | 500,000 | +42.9% | 0.87% | -6.7% |
| CCXI | New | CHEMOCENTRYX INC | $14,564,000 | – | 400,000 | +100.0% | 0.87% | – |
| GHRS | GH RESEARCH PLCordinary shares | $14,188,000 | +7.9% | 608,123 | 0.0% | 0.84% | +58.1% | |
| ACET | New | ADICET BIO INC | $13,118,000 | – | 750,000 | +100.0% | 0.78% | – |
| ACRS | Sell | ACLARIS THERAPEUTICS INC | $13,086,000 | -51.5% | 900,000 | -40.0% | 0.78% | -29.1% |
| ELEV | ELEVATION ONCOLOGY INC | $11,939,000 | -21.1% | 1,983,165 | 0.0% | 0.71% | +15.4% | |
| Sell | TYRA BIOSCIENCES INC | $11,605,000 | -36.1% | 839,932 | -21.5% | 0.69% | -6.5% | |
| LBPH | LONGBOARD PHARMACEUTICALS IN | $11,069,000 | -45.1% | 2,273,221 | 0.0% | 0.66% | -19.7% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $11,002,000 | -48.2% | 75,000 | -37.5% | 0.65% | -24.2% |
| VECT | Sell | VECTIVBIO HLDG AG | $10,884,000 | -36.7% | 2,216,763 | -0.4% | 0.65% | -7.4% |
| PHVS | PHARVARIS N V | $9,925,000 | -18.8% | 689,731 | 0.0% | 0.59% | +18.7% | |
| ZYME | Sell | ZYMEWORKS INC | $9,834,000 | -64.4% | 600,000 | -36.8% | 0.58% | -47.8% |
| ICOSAVAX INC | $9,756,000 | -20.3% | 426,393 | 0.0% | 0.58% | +16.7% | ||
| KROS | New | KEROS THERAPEUTICS INC | $8,776,000 | – | 150,000 | +100.0% | 0.52% | – |
| AKRO | Sell | AKERO THERAPEUTICS INC | $8,540,000 | -36.3% | 403,787 | -32.7% | 0.51% | -6.8% |
| New | PYXIS ONCOLOGY INC | $7,117,000 | – | 668,854 | +100.0% | 0.42% | – | |
| ITOS | Sell | ITEOS THERAPEUTICS INC | $6,984,000 | -10.3% | 150,000 | -48.0% | 0.42% | +31.3% |
| ASND | Sell | ASCENDIS PHARMA A/Ssponsored adr | $6,726,000 | -75.2% | 50,000 | -70.6% | 0.40% | -63.7% |
| PLRX | PLIANT THERAPEUTICS INC | $6,513,000 | -20.0% | 482,413 | 0.0% | 0.39% | +16.9% | |
| ALGS | Sell | ALIGOS THERAPEUTICS INC | $6,187,000 | -40.2% | 521,257 | -21.9% | 0.37% | -12.4% |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $5,931,000 | +5.3% | 300,000 | -12.4% | 0.35% | +54.1% |
| ELDN | ELEDON PHARMACEUTICALS INC | $5,755,000 | -28.6% | 1,305,095 | 0.0% | 0.34% | +4.3% | |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $4,863,000 | -65.9% | 300,000 | -40.0% | 0.29% | -50.2% |
| CABA | Sell | CABALETTA BIO INC | $4,375,000 | -77.7% | 1,154,424 | -28.4% | 0.26% | -67.3% |
| HLXA | HELIX ACQUISITION CORP | $4,253,000 | -0.5% | 430,000 | 0.0% | 0.25% | +45.4% | |
| HARP | HARPOON THERAPEUTICS INC | $4,082,000 | -4.4% | 540,600 | 0.0% | 0.24% | +39.7% | |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $3,864,000 | – | 100,000 | +100.0% | 0.23% | – |
| RENOVACOR INC | $3,850,000 | -14.9% | 500,000 | 0.0% | 0.23% | +24.5% | ||
| MGTX | New | MEIRAGTX HLDGS PLC | $3,561,000 | – | 150,000 | +100.0% | 0.21% | – |
| ANAB | Sell | ANAPTYSBIO INC | $3,475,000 | -66.7% | 100,000 | -74.0% | 0.21% | -51.2% |
| AKUS | AKOUOS INC | $3,353,000 | -26.8% | 394,500 | 0.0% | 0.20% | +7.0% | |
| MRUS | Sell | MERUS N V | $3,180,000 | -42.2% | 100,000 | -60.0% | 0.19% | -15.2% |
| GLTO | Sell | GALECTO INC | $3,091,000 | -25.2% | 1,020,238 | -11.3% | 0.18% | +9.5% |
| ASTRIA THERAPEUTICS INC | $2,980,000 | -39.0% | 552,903 | 0.0% | 0.18% | -11.1% | ||
| DTIL | PRECISION BIOSCIENCES INC | $2,564,000 | -35.9% | 346,524 | 0.0% | 0.15% | -5.6% | |
| GRPH | GRAPHITE BIO INC | $2,525,000 | -22.6% | 203,153 | 0.0% | 0.15% | +12.8% | |
| GOSS | GOSSAMER BIO INC | $2,244,000 | -10.0% | 198,382 | 0.0% | 0.13% | +31.7% | |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $2,035,000 | -20.8% | 392,167 | 0.0% | 0.12% | +16.3% | |
| QURE | Sell | UNIQURE NV | $1,037,000 | -86.5% | 50,000 | -79.1% | 0.06% | -80.1% |
| CNTB | Sell | CONNECT BIOPHARMA HLDGS LTDads | $1,030,000 | -91.4% | 200,000 | -60.0% | 0.06% | -87.4% |
| New | SONENDO INC | $859,000 | – | 149,200 | +100.0% | 0.05% | – | |
| BCEL | ATRECA INC | $829,000 | -51.3% | 273,500 | 0.0% | 0.05% | -29.0% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $339,000 | -42.5% | 256,649 | 0.0% | 0.02% | -16.7% | |
| IMV | IMV INC | $289,000 | -24.9% | 234,374 | 0.0% | 0.02% | +6.2% | |
| XFOR | X4 PHARMACEUTICALS INC | $238,000 | -56.7% | 103,980 | 0.0% | 0.01% | -36.4% | |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $32,000 | -40.7% | 270,698 | 0.0% | 0.00% | 0.0% | |
| NERV | Exit | MINERVA NEUROSCIENCES INC | $0 | – | -95,744 | -100.0% | -0.01% | – |
| QTNT | Exit | QUOTIENT LTD | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
| SRNE | Exit | SORRENTO THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.12% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -478,200 | -100.0% | -0.14% | – |
| TCRR | Exit | TCR2 THERAPEUTICS INC | $0 | – | -479,506 | -100.0% | -0.17% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -144,439 | -100.0% | -0.20% | – |
| MORF | Exit | MORPHIC HLDG INC | $0 | – | -100,000 | -100.0% | -0.23% | – |
| Exit | APTOSE BIOSCIENCES INC | $0 | – | -3,000,000 | -100.0% | -0.27% | – | |
| MYOV | Exit | MYOVANT SCIENCES LTD | $0 | – | -300,000 | -100.0% | -0.27% | – |
| VERU | Exit | VERU INC | $0 | – | -800,000 | -100.0% | -0.28% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.34% | – |
| Exit | DERMTECH INC | $0 | – | -300,000 | -100.0% | -0.39% | – | |
| RETA | Exit | REATA PHARMACEUTICALS INCcl a | $0 | – | -100,000 | -100.0% | -0.41% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -48,132 | -100.0% | -0.46% | – |
| OMER | Exit | OMEROS CORP | $0 | – | -950,000 | -100.0% | -0.53% | – |
| IMAB | Exit | I MABsponsored ads | $0 | – | -200,000 | -100.0% | -0.59% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -150,000 | -100.0% | -0.63% | – |
| AGEN | Exit | AGENUS INC | $0 | – | -4,807,557 | -100.0% | -1.03% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| QUOTIENT LTD | 30 | Q3 2021 | 4.3% |
| ASCENDIS PHARMA A/S | 30 | Q4 2022 | 4.8% |
| MINERVA NEUROSCIENCES INC | 29 | Q3 2021 | 4.4% |
| ACCELERON PHARMA INC | 28 | Q2 2021 | 3.4% |
| OMEROS CORP | 27 | Q3 2021 | 6.5% |
| MIRATI THERAPEUTICS INC | 25 | Q4 2022 | 7.6% |
| BLUEPRINT MEDICINES CORP | 25 | Q3 2021 | 3.6% |
| APELLIS PHARMACEUTICALS INC | 24 | Q3 2023 | 8.6% |
| NEUROCRINE BIOSCIENCES INC | 24 | Q1 2020 | 4.6% |
| ROCKET PHARMACEUTICALS, INC | 23 | Q3 2023 | 2.4% |
View Cormorant Asset Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ambrx Biopharma Inc. | March 13, 2023 | 42,771,365 | - |
| Altimmune, Inc. | February 14, 2023 | 2,600,000 | - |
| Arcellx, Inc. | February 14, 2023 | 2,075,000 | - |
| BioAtla, Inc. | February 14, 2023 | 2,499,250 | - |
| Eledon Pharmaceuticals, Inc. | February 14, 2023 | 1,391,663 | - |
| GreenLight Biosciences Holdings, PBC | February 14, 2023 | 4,751,020 | - |
| Prometheus Biosciences, Inc. | February 14, 2023 | 700,000 | - |
| Tango Therapeutics, Inc. | February 14, 2023 | 1,000,000 | - |
| VectivBio Holding AG | February 14, 2023 | 1,515,087 | - |
| Viridian Therapeutics, Inc.\DE | February 14, 2023 | 1,100,000 | - |
View Cormorant Asset Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-22 |
| SC 13G/A | 2024-04-15 |
| 4 | 2024-04-03 |
| SC 13G | 2024-03-21 |
| 4 | 2024-03-18 |
| SC 13G/A | 2024-03-18 |
| 4 | 2024-03-11 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Cormorant Asset Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.